Intersect ENT Inc. | Mutual Funds
Mutual Funds that own Intersect ENT Inc.
Invesco Small Cap Growth Fund
703,656
2.31%
89,356
0.63%
06/29/2018
Vanguard Total Stock Market Index Fund
698,612
2.29%
0
0%
07/31/2018
Prudential Jennison Small Company Fund, Inc.
693,627
2.27%
-12,097
0.54%
07/31/2018
iShares Russell 2000 ETF
620,106
2.04%
-330
0.04%
09/06/2018
Federated Kaufmann Fund
575,000
1.89%
-350,000
0.25%
06/29/2018
AB Small Cap Growth Fund
558,510
1.83%
-21,110
0.88%
07/31/2018
Wellington Mgmt. Port (Dublin) Plc - Global Health Care Eq.
494,022
1.62%
58,022
0.67%
12/31/2017
JNL/Invesco Small Cap Growth Fund
405,844
1.33%
405,844
0.54%
03/31/2018
Variopartner SICAV - MIV Global Medtech Fund
373,000
1.23%
0
0.76%
05/31/2018
Vanguard Extended Market Index Fund
371,059
1.22%
5,500
0.02%
07/31/2018
| Address |
1555 Adams Drive
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.intersectent.com |
| Updated |
07/08/2019 |
| Intersect ENT, Inc. is acommercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. |
